Introduction
Today, most major programmes in Neuroscience and Psychology have their own functional imaging systems and laboratories. We can assess haemodynamic & 2016 The Author(s) Published by the Royal Society. All rights reserved.
changes with functional Magnetic Resonance Imaging (fMRI) and functional Near-Infrared Spectroscopy, broad regional electrical activity with magneto/electroencephalography (MEG/ EEG) and metabolism/neurochemistry with Positron Emission Tomography. And yet, despite this widespread adoption, the power of available human neuroimaging methods remains limited, leaving a gap between the macroscopic activity patterns available in humans and the rich, detailed view achievable in model organisms. Thus, a central challenge facing neuroscience today is leveraging these mechanistic insights from animal studies to accurately draw physiological inferences from noninvasive signals in humans, essentially asking the fundamental question: what information about neuronal circuit activity can we reliably determine from non-invasive functional imaging in humans? This question has been approached by many investigators in different ways [1] [2] [3] [4] [5] [6] , and our goal is not to provide a detailed review of this work. Instead, in this opinion article our goal is to outline a particular approach-a roadmap-based on our recent work that has the potential to provide the basis for a deeper interpretation of functional imaging in humans.
Our specific focus is on the physiological underpinning of Blood Oxygenation Level Dependent (BOLD) fMRI [7, 8] combined with MEG/EEG [9, 10] in the healthy cerebral cortex. The central physiological phenomenon underlying the BOLD effect is that, in areas that experience an increase in neuronal activity, cerebral blood flow (CBF) usually increases much more than cerebral metabolic rate of oxygen (CMRO 2 ), leading to an increase in blood and tissue oxygenation that drives the BOLD fMRI signal up. The biological function of this imbalance of CBF and CMRO 2 is still not fully understood, but is likely to be a mechanism to prevent the tissue O 2 concentration from falling when CMRO 2 increases [2, [11] [12] [13] . Thus, the BOLD signal reflects neuronal activity only indirectly through its relationship with CBF and CMRO 2 . Furthermore, increasing CBF and CMRO 2 pushes the BOLD signal in opposite directions adding to the difficulty in interpretation (figure 1). If the ratio of CBF and CMRO 2 changes remained constant, the BOLD signal could still be a reliable metric for the magnitude of neuronal activity change, but there is now substantial evidence that CBF/CMRO 2 coupling varies in the same brain region with stimulus intensity, attention, adaptation and after ingestion of caffeine [14, 15] .
As a result of these limitations, in current practice we do not know how to interpret BOLD fMRI studies in terms of the underlying brain physiology even at the vascular/haemodynamic level in the healthy human brain, let alone in ageing and disease. The intrinsic ambiguities of the BOLD signal underscore the importance of a multimodal imaging approach [16] . The motivation for the current paper is the idea that, while the BOLD signal alone is fundamentally ambiguous, the combination of BOLD imaging with arterial spin labelling (ASL) methods and the 'calibrated BOLD' approach (a.k.a. 'quantitative fMRI') makes it possible to isolate the effects of CBF and CMRO 2 -the macroscopic physiological parameters directly related to neurovascular and neurometabolic coupling [17] [18] [19] . This means that neuronal activity patterns that differentially affect CBF and CMRO 2 (e.g. net excitation versus net inhibition) may be distinguishable with calibrated BOLD. Furthermore, more detailed, time-resolved information about activity of cell-type-specific neuronal populations may become available from a combination of calibrated BOLD with MEG/EEG, as long as these populations differentially contribute to macroscopic electrical signals detectable from the brain surface.
We emphasize cell-type-specific populations rather than single neurons because brains of mammals, including mice and humans, appear to be built from large populations of neurons collectively performing similar function in a probabilistic way. This is in contrast to invertebrates such as the nematode Caenorhabditis elegans where a few individually identified neurons can govern specific behaviours [20] . Thus, for human neuroimaging, interpreting the data in terms of the respective activity levels of cell-type-specific neuronal populations may be sufficient for understanding circuit dynamics.
The ongoing large initiatives such as The BRAIN Initiative in the US and the Human Brain Project in Europe, which aim to develop new experimental and computational technologies and platforms, will undoubtedly advance our ability to probe functional organization of the human brain [21 -23] . However, already today we can start tackling the challenge of extracting cell-type-specific neuronal activity from non-invasive imaging by designing parallel experiments in animals and humans, integrating existing measurement modalities and building computational bridges across scales. Conceptual relationship between physiological parameters and measurements in mice and humans across scales. Advancing our ability to infer microscopic details of underlying physiology in the human brain from non-invasive methods requires parallel data acquisition in animals (e.g. mice) and humans, and a complementary theoretical effort building computational bridges between the varying scales as well as from animals to humans. Animal experiments are necessary to directly measure and manipulate concrete cellular-level physiological parameters. These measurements, which are only available in model organisms, provide the microscopic 'ground truth' needed for the development of theoretical models. In parallel, multimodal non-invasive human data are needed to evaluate translation.
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To illustrate this approach, we focus on the primary somatosensory cortex (SI) where 'bottom-up' models can be built and calibrated taking advantage of well-studied neuronal network phenomena such as the surround and transcallosal inhibition [24] [25] [26] [27] [28] [29] . In animals (e.g. mice), we can use microscopic measurement technologies to precisely and quantitatively probe concrete microscopic neuronal, vascular and metabolic parameters while manipulating cell-type-specific neuronal activity (figure 1, blue boxes). These microscopic data can then be used to simulate the corresponding macroscopic physiological parameters (CBF, CMRO 2 and current dipole moment) and their reflection in non-invasive observables (figure 1, red boxes) [30] [31] [32] . Thus, in mice, we can develop a detailed forward model bridging neuronal activity at the level of cell-type-specific populations to non-invasive imaging signals. Furthermore, we can validate this model at each step against real data. For human translation, first we would have to calibrate the model parameters to account for systematic differences due to known physical scaling laws such as differences in vessel size or latency of the cortical neuronal response. Then, the remaining uncertainty in the translation of model parameters from mouse to human (as well as the measurement noise and subject-to-subject variability) would be factored into a single Bayesian estimation framework [33] to obtain estimates of the parameters of interest (i.e. activity of cell-type-specific neuronal populations) and quantify the uncertainty of estimation.
In this context, the key question is: What is the evidence for the differential vasoactive role, energetic costs and electrical currents/potentials associated with activity of different neuronal cell types? That is, are there cell-type-specific signatures in terms of how activity of a particular type of neurons affects CBF, CMRO 2 and current dipole? If so, multimodal noninvasive imaging could potentially provide a much more specific window on neuronal circuit activity in humans. The remainder of the paper is a roadmap for reaching that end.
Microscopic regulation of dilation and constriction
A growing body of data increasingly suggests that differential vascular control originates from activation of specific neuronal sub-populations through release of vasoactive signalling molecules [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] . In vitro (brain slice) studies in cerebral and cerebellar cortices have demonstrated that spiking of specific types of neurons can cause dilation or constriction of nearby arterioles [41, 45] . In vivo studies revealed a correlation between arteriolar constriction and neuronal inhibition (figure 2a-e) [38, 46, 47] . The vasoconstriction was abolished by blocking of neuronal activity [38] and was found on the arterial side while venous diameters stayed unchanged [48, 49] suggesting an active process rather than a passive 'blood steal'. This conclusion was further supported by a modelling study [30] . These observations are consistent with reports of negative BOLD signals in cortical regions that are expected to experience inhibition such as those surrounding the centre of the neuronal response (a.k.a. 'surround inhibition') and in the ipsilateral hemisphere [29, 46, [50] [51] [52] [53] [54] . Some of these studies used simultaneous extracellular recording of multiunit spiking activity to provide evidence of a decrease in neuronal firing (i.e. inhibition) spatially coincident with the negative BOLD signal [46] . Dilation (and constriction) propagates along vascular walls [55] [56] [57] [58] . Therefore, identifying the location of the earliest dilation is important for isolation of the local rather than conducted neurovascular mechanisms. A body of work has documented the temporal properties of stimulus-induced diameter changes in surface (pial) arterioles, diving arteriolar trunks, and their initial lateral branches (the first three to four branching orders off the diving trunk) [38, 47, [59] [60] [61] [62] . Twophoton measurements at different depths revealed that the earliest dilation onset occurs in deep cortical layers, below layer IV (in the mouse, dilation in layer V starts approx. 500 ms prior to that in layer I) [63] . The dilation latency gradually increases with decreasing cortical depth ( figure 2f,g ) [59] [60] [61] 63] and, in the upper layers, also with increasing branching order such that diving trunks precede their side branches (figure 2h) [59] . The overall picture is consistent with propagation of dilation from the deep layers towards the cortical surface along diving arterioles, invading lateral arteriolar branches on the way. These findings do not imply that propagation within the vascular wall is the only mechanism behind the observed timing gradients and do not rule out local neurovascular communication in the upper layers. In the presence of both local and conducted signalling, the onset of dilation would be determined by the faster of the two processes. However, substantial delays in the superficial arteriolar branches suggest that local neurovascular communication in the upper layers, if it exists, has slower kinetics. Gaining insight into the mechanisms generating these temporal differences would lead to better understanding of neurovascular coupling.
These temporal gradients are robust in our hands, but remain controversial in the field. As such, the gradual decrease in the latency of dilation with depth is in agreement with a depth-resolved fMRI study in humans [64] but at odds with a recent high-resolution fMRI study in rats [65] . This discrepancy, however, may reflect the complex nature of the BOLD signal that depends on the balance between O 2 delivery and consumption as well as on the measurement theory specific to the chosen data-acquisition paradigm. Two-photon diameter measurements, on the other hand, are direct and assumptionfree. A controversy exists also regarding the dependence on the branching order. Specifically, one study reported that stimulus-induced dilation of low-order branches, traditionally known as the 'precapillary arterioles', can precede their parent diving arteriolar trunks [62] ; the same study unconventionally labelled these low-order branches as capillaries. The reason for the discrepancy between this result and data from our studies is unclear. While the low-order branches (that may include true capillaries) can dilate and constrict, high-order branches, i.e. capillaries in the bulk capillary bed, do not possess contractile elements and therefore lack active dilation or constriction [66] [67] [68] . The same applies to veins although a slow and passive increase in the venous volume in response to a steady-state increase in neuronal activity has been reported [69] .
Two-photon single-vessel measurements can be combined with optogenetic (OG) stimulation, opening the door to study neurovascular regulation with an unprecedented level of specificity ( figure 3a,b) . Because different types of neurons are wired together in intact cerebral circuits, they are co-activated during neuronal events, e.g. during the responses to an external stimulus. For this reason, isolation of cell-type-specific neuronal activity in vivo was virtually impossible prior to the arrival of optogenetics [70] . The currently available OG tools offer both rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 371: 20150356 activation and inactivation of many neuronal cell types [71] . To ensure specificity in such an experiment, care should be taken to prevent the spread of activation to other neuronal cell types. For example, unless synaptic communication is inhibited, OG activation of excitatory pyramidal cells (PCs) may not provide an advantage for the study of neurovascular coupling over sensory stimulation: in both cases firing of many neuronal cell types results in the release of a mixture of neurotransmitters and peptides. Using OG stimulation and two-photon imaging, we recently demonstrated that excitatory and inhibitory neurons drive parallel dilatory pathways while virtually the entire constriction response was explained by Neuropeptide Y (NPY) presumably released from a specific class of inhibitory neurons expressing NPY (figure 3c-h) [63] . OG stimulation can be employed in haemodynamic studies also through combination with fMRI and single-photon haemodynamic measurements [72] [73] [74] [75] [76] .
Release showing fast astrocytic kinetics [85] . This fast signal, however, could have resulted from a cross-talk with neuronal Ca þþ activity. Thus, the role of Ca þþ -dependent release of astrocytic vasoactive compounds in CBF regulation remains controversial. In addition, we cannot rule out (currently unknown) Ca þþ -independent pathways as well as a potential astrocytic role in sustaining dilation in response to a long-duration increase in neuronal activity. Furthermore, the phenomenon of glial Ca þþ excitability differs between brain regions [86, 87] , such that the role of glia in neurovascular communication may not directly translate from one region to the other.
Release of vasoactive messengers is not the only possible neurovascular communication mechanism. In fact, attempts at blocking the dilation response using a cocktail of pharmacological blockers for all known neuronal and astrocytic vasoactive messengers have not been successful [88] . In addition to trivial explanations such as incomplete drug coverage or unknown messenger molecules, the residual dilation may be due to vasoactive metabolites or K þ . Vasoactive properties of certain energy metabolites (e.g. lactate and CO 2 ) are well documented [89] [90] [91] [92] . However, cases of dissociation between the dilation response and energy consumption on the microscopic scale in vivo suggest that, under normal physiological conditions, accumulation of these vasoactive bi-products may not be sufficient to dominate CBF regulation [38] . While vasoactive metabolites may reach concentrations relevant for CBF regulation only in disease (e.g. cortical spreading depression, epileptic seizures, hypoxia) extracellular K þ may act as a dilator within its normal physiological range [93] [94] [95] . K þ is released by all spiking neurons and can activate K ir channels in the arteriolar smooth muscle causing hyperpolarization and relaxation (i.e. vasodilation) [95] . K ir channels are also present in the endothelial cells [96] and can underlie EC-mediated propagation of signalling along the vascular wall [97] . Glial role in K þ transport from the extracellular to perivascular space (known as 'K þ siphoning') has also been proposed but remains controversial [98] [99] [100] . Although further studies are required to document the role of K ir channels in local and conducted vasodilation in vivo, one or more of these K þ -mediated mechanisms may account for the residual dilation response insensitive to the blockers of molecular signalling.
Thus, although multiple vasoactive mechanisms have been identified, not all of them act at once. Rather, specific pathways are likely to be selectively involved depending on: (i) timescales, e.g. initiation and sustaining of dilation; (ii) physiological or pathological conditions, e.g. normal stimulus-induced hyperemia or CBF increase in response to a seizure; (iii) local or global/regional nature of CBF regulation; and (iv) proximity to the site of the initial dilation (locally induced or conducted responses). Under normal physiological conditions, neuronal signalling seems to play the dominant role in driving arteriolar dilation and constriction. In addition, rises in the extracellular K þ associated with neuronal firing may contribute to both local and conducted response. In disease, aberrant neuronal activity and upregulation of astrocytic Ca þþ excitability can lead to the release of vasoactive astrocytic messengers and accumulation of vasoactive metabolites (e.g. lactate) 'taking over' the CBF control [101 -103] . 
Microscopic O 2 transport and consumption
A large body of experimental studies has established the basic properties of intra-and extravascular oxygen changes during changes in neuronal activity [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] powering biophysical modelling of O 2 transport and consumption [115] [116] [117] [118] . Recently, our ability to measure O 2 with microscopic resolution has been revolutionized by the arrival of specific optical probes excitable in the two-photon regime [119] [120] [121] and the development of two-photon phosphorescence lifetime microscopy (2PLM) [122] . 2PLM allows measurement of both intravascular and tissue-partial pressure of O 2 ( pO 2 ) with unprecedented spatial resolution, and is well suited to imaging of pO 2 changes at the baseline as well as during functional activation (figure 5a-e) [13, [123] [124] [125] [126] . 2PLM can also be used to estimate blood flow in individual capillaries simultaneously with the intracapillary pO 2 [125] .
2PLM offers a novel method for quantitation of CMRO 2 based on pO 2 gradients immediately surrounding diving arterioles (figure 5a) [13] . This method is based on the assumption that peri-arterial tissue-the area within an approximate 100 mm radius around a diving arteriole-receives all of its O 2 from the arteriole. Several properties of the cortical vasculature justify this assumption. First, two-photon imaging of the vascular architecture in the rat and mouse SI indicates the absence of capillaries around diving arterioles [127] . Second, two-photon measurements of tissue pO 2 around diving arterioles show large gradients-a decrease in tissue pO 2 moving away from the diving arteriole-implying significant O 2 delivery from the arteriole (figure 5a,b) [13] . Third, two-photon measurements of intravascular pO 2 within diving arterioles demonstrate a pO 2 decrease moving from the vessel centre to the arteriolar wall indicating that O 2 leaves through the arteriolar wall (figure 5f ) [123] . Fourth, the intravascular pO 2 of diving arterioles decreases with increasing cortical depth, again implying O 2 delivery from the arteriole [123] . This last finding, originally reported under anaesthesia, was not reproduced by a recent study in awake mice [128] . This discrepancy, however, may be explained by the higher blood-flow velocity resulting in lower O 2 extraction fraction. In other words, diving arterioles are likely to supply O 2 also in awake mice, but produce a negligible effect on the intravascular pO 2 due to high flux of red blood cells. Measurements of tissue pO 2 in awake mice will be required to confirm this prediction.
Overall, this organization agrees with Krogh's model of O 2 diffusion from a cylinder (figure 5g) [129] where the required condition is a single O 2 source in the middle of the tissue cylinder-the diving arteriole. This model is described by the following equation:
where r is the radial distance from the arteriolar wall, pO 2,A is tissue pO 2 measured at the outer vessel wall boundary, R A is vessel radius, D is tissue O 2 diffusivity and a is tissue O 2 solubility. The Krogh model also includes an external tissue radius R t which is estimated as the radius where pO 2 gradient is zero (a fitted parameter in the calculation along with CMRO 2 ). Assuming that CMRO 2 is uniform for a particular cortical layer, the estimate obtained from the peri-arteriolar tissue can be treated as representative CMRO 2 within a cortical column (200-300 mm in diameter in the mouse SI). The assumption of uniform CMRO 2 is based on the locally uniform distribution of neuronal and glial cells in the cortex-the absence of anatomical differences between peri-arterial spaces and other cortical regions [130] . Therefore, while at the cellular scale CMRO 2 may be heterogeneous, CMRO 2 based on the area within an approximate 100 mm radius around a diving arteriole should represent an accurate local estimate. The Krogh model can be extended to the dynamic regime (i.e. changes in CMRO 2 induced by neuronal response to a stimulus) by considering two parallel processes: diffusion of O 2 from the arteriole and consumption of O 2 by tissue [131] . In the future, a combination of 2PLM with OG stimulation will allow profiling of O 2 consumption associated with activity of specific neuronal cell types and across different respective levels of excitatory and inhibitory activity.
Since under normal physiological conditions neurovascular and neurometabolic coupling occur in parallel (figure 1), we must think of CBF and CMRO 2 as being driven in parallel by neuronal activity, and potentially by different aspects of neuronal activity: the CBF response is determined by the dilatory and constrictive agents released from active neurons while CMRO 2 response directly reflects the energetic costs (associated mainly with neuronal repolarization [39, 132] ).
Bridging across spatial scales: from singlevessel dilation to macroscopic cerebral blood flow and cerebral metabolic rate of oxygen
Understanding neurovascular mechanisms requires access to concrete microscopic parameters with high-resolution, sensitivity and specificity. While such measurements are achievable in animal experiments, non-invasive imaging in humans is limited (at least, in its current practice) in resolution and, often, by the indirect nature of the measured signals. This is due to a complex relationship between the measured non-invasive signals and the underlying physiological variables (a.k.a. the 'measurement theory' problem). Therefore, individual microscopic measurements have to be integrated within a computational model in order to reconstruct the phenomenon on the macroscopic scale.
One example of such a model is the vascular anatomical network (VAN) that allows a detailed, 'bottom-up' simulation of macroscopic CBF and CMRO 2 [30] [31] [32] . This model is based on a realistic three-dimensional cortical microvascular network (e.g. 600 Â 600 Â 600 mm in Gagnon et al. [32] ) populated with experimentally obtained microscopic measurements of pO 2 (from 2PLM) and CBF (using optical coherence tomography). A three-dimensional microvascular angiogram can be obtained in vivo using two-photon microscopy followed by graphing and segmentation of the vascular network: from the pial arterioles, through the capillary network to the pial veins (figure 6a-c). pO 2 distributions are then obtained by modelling O 2 transport and consumption using the advection-diffusion equation [133] with the experimental data serving as boundary conditions. For simulation of activation dynamics, experimentally obtained time courses of dilation (e.g. as a function of the cortical depth and branching order) are used as the input to the VAN model for calculation of stimulus-induced changes in CBF and oxygen distribution (figure 6d).
Furthermore, the VAN model permits simulation of magnetic field perturbations as a function of specific pulsesequence parameters to predict the fMRI signal from first principles. This is done by calculation of the microscopic distortions in the magnetic field arising from the spatio-temporal distribution of deoxygenated haemoglobin. Keeping track of changes in the intravascular deoxygenated haemoglobin, resulting from the dynamics of vasodilation and O 2 consumption, one can simulate the dephasing of protons, excited by different pulse sequences, as they diffuse through the heterogeneous magnetic field (figure 6e,f). These predictions can then be contrasted against real fMRI data to ensure validity of the model [32] . Using arteriolar diameter and pO 2 measurements in response to OG activation of specific neuronal cell types as the input, the VAN model can be used to estimate the macroscopic CBF and CMRO 2 effects driven by the individual neuronal populations.
5. Bridging across spatial scales: from activity of specific neuronal cell types to macroscopic current dipole
The need to bridge between the micro-and macroscopic scale also applies to non-invasive measurements of neuronal electrical activity obtained with MEG or EEG that reflect the same physical process but differ in their relative sensitivity to current dipoles depending on their orientation and depth [134] . The MEG/ EEG signals are dominated by intracellular currents flowing up and down the cortical column along cortical PCs [135] . This is because in cerebral cortex PCs are aligned along the depth axis forming a preferred orientation for the current flow that can be captured from distance as the current dipole moment.
Other cell types lack a preferred orientation (e.g. excitatory stellate cells or parvalbumin-positive inhibitory basket cells) and/ or are present in small numbers (e.g. bipolar inhibitory neurons) compared with PCs [136] such that their contribution to the MEG/EEG signal is expected to be negligible. Localization of current dipole from MEG/EEG data is a difficult problem that has been addressed by many groups using experimental and computational methods [9, 135, 137] . In the absence of additional priors, this problem is illposed. In the SI, however, the location of neuronal activity is known due to somatotopic maps. These maps can be validated/refined for each subject using fMRI. Thus, we can obtain locations of cortical signal generators from fMRI and get accurate estimation of the time course of neuronal activity from EEG/MEG [10, 138] .
The dipole moment can be forward-calculated using depth-resolved (laminar) extracellular recordings of Local Field Potential (LFP) [139] . The laminar LFP profiles can be used to obtain laminar Current Source Density (CSD) [140] . Then, the dipole moment is computed as the moment of the current sources and sinks along the cortical depth [141, 142] (figure 7a,b) . To generate a measurable dipole, synaptic inputs have to arrive either at the top of PC dendritic tree (apical dendrites) or at the bottom (the soma and basal dendrites) [150, 151] . Inputs covering the entire length of a PC or those arriving exactly at the middle would not generate a dipole. Fortunately, synaptic projections (i.e. projection 'domains') from at least some types of inhibitory neurons onto PCs segregate along the depth axis (figure 7c) [143, 152] . For example, somatostatin-positive Martinotti cells synapse on the apical dendrites [153] while double bouquet cells positive for neuronal nitric oxide synthase synapse at the basal dendrites [143] . These different patterns of synaptic projections onto PCs are expected to produce distinguishable laminar LFP profiles, and some of these differences will survive in the corresponding current dipole. For this reason, MEG/EEG signals can offer additional constraints for the interpretation of fMRI data in terms of activity of neuronal cell-type-specific populations. As such, different types of inhibitory neurons may produce constriction (such as NPY), dilation, or have no vasoactive effect. However, even when multiple types of inhibitory neurons have the same vasodilatory effect, they may differ in the laminar profile of their synaptic projection domains onto PCs resulting in distinct contributions to the current dipole.
Thus, the idea would be to build a library of the laminar LFP profiles due to OG stimulation of specific neuronal cell types (e.g. Martinotti cells). The reason for using OG stimulation would not be to reproduce natural or balanced neuronal activity patterns. Rather, the goal is to produce artificially selective activation of specific neuronal populations for isolation of their electrical (as well as vasoactive and metabolic) effects. A natural laminar LFP profile (or the current dipole)-such as that induced by a sensory stimulus in an intact cortical neuronal circuit-can then be viewed as a weighted linear superposition of these population-specific 'primitives' (due to the linear superposition nature of electromagnetic signals [10, 138, 139] ).
Experimental estimation of these primitives requires selective activation of a specific population of presynaptic neurons, which can be achieved using optogenetics. A combination of OG activation of a presynaptic population j with the laminar LFP recordings would provide a CSD profile resulting from currents in all PCs postsynaptic to j. To obtain CSD profiles specific to a particular population of PCs (those with the cell body located in layer II/III, layer V or layer VI), one can employ computational decomposition methods [142, 154] . Furthermore, detailed 'realistic' models of cortical columns have recently become available due to a decade-long effort by The Blue Brain Project currently continuing under the umbrella of The Human Brain Project. These models of synaptically connected spiking neurons with realistic morphologies can be combined with the physical principles governing generation rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 371: 20150356 of LFP [155, 156] for prediction of LFP/CSD/dipole signals resulting from complex circuit phenomena. These models also allow testing for potential non-additive effects resulting from active conductances (e.g. the Ca þþ spike in PCs [157] ).
Given experimentally derived knowledge on the vasoactive role and energetic costs of activity for the individual cell-type-specific neuronal populations, we may be able to use neuronal network models to predict CBF and CMRO 2 changes associated with specific circuit activity patterns. Translation to macroscopic fMRI signals, however, would still require models like VAN that take into account vascular structure and the MRI measurement theory, such as sensitivity of the fMRI signal to specific vascular compartments or orientation of the main magnetic field relative to blood vessels.
6. Estimation of cell-type-specific neuronal activity from macroscopic cerebral blood flow, cerebral metabolic rate of oxygen and current dipole where DF(t), DC(t) and DD(t) are the observed macroscopic CBF, CMRO 2 and the current dipole moment, respectively; W fj (t), W cj (t) and W dj (t) are weighting factors per unit activity for neuronal population of cell type j; DS j (t) is the amplitude of neuronal activity for the population j and represents a temporal convolution. As the release of vasoactive signalling molecules (and K þ ) in neurons normally requires spike-induced depolarization, we think of DS j (t) as the cell-type-specific spiking response. This should not be interpreted as settling the classical question of whether spiking or synaptic activity correlates better with BOLD in favour of spiking. Historically, this question was motivated by the idea of a metabolic feedback. This idea postulated that CBF increase was mechanistically driven by the accumulation of vasoactive energy metabolites [92] . In our view, on the other hand, neurovascular coupling under normal conditions is governed by a feed forward mechanism, where specific vasoactive signalling agents released by active neurons drive dilation and constriction, depending on the cell type. For CBF and CMRO 2 , DS j (t) in equations (6.1) and (6.2) can be approximated as a delta function locked to an individual neuronal event (as long as neuronal events are brief on the haemodynamic timescale) and W j (t)DS j (t)-as a scaled cell-type-specific impulse response function. Electrophysiological signals, by contrast, are measured on the actual temporal scale of neuronal activity. Therefore, for DD(t) (equation (6.3) ), DS j (t) represents a time course of spiking activity for the cell type j. As DS j (t) in equation (6.3) stands for spiking and DD(t) reflects currents (flowing up and down PC dendrites), the cell-type-specific weighting factor W dj (t) can be thought of as the transfer function from the presynaptic spikes in cell type j to postsynaptic currents in PCs. As some of us described previously [142] , cell-type-specific laminar CSD can be expressed as the presynaptic spiking activity convolved with an exponential function representing the resulting postsynaptic currents in PCs. Therefore, W dj (t) represent the dipole moment of these postsynaptic currents. Finally, the formalism described in equations (6.1)-(6.3) is based on the assumption of linearity. The validity of this assumption can be evaluated experimentally by performing direct measurements of DS j (t) in response to the sensory stimulus (e.g. using cell-type-specific expression of genetically encoded Ca þþ probes) and comparing the measured and estimated DS j (t) across stimulus conditions. In the simplest case of two considered cell typesexcitatory and inhibitory-we would have only two unknowns: DS j for excitation and inhibition. Based on our recent study attributing vasoconstriction in vivo to activation of NPY-positive inhibitory neurons ( figure 3 ) [63] , we predict that W f (t) for excitatory and inhibitory neurons will integrate to a positive and negative number, respectively. Therefore, at steady state ('blocked' experimental design), we would obtain positive DF (an increase in CBF) for excitation and negative DF (a decrease in CBF) for inhibition. This would be consistent with vasoconstriction and negative BOLD previously observed by us and others in the ipsilateral hemisphere experiencing transcallosal inhibition [29, 38, 50, 53] . For DC, we expect a smaller increase in DCMRO 2 due to activity of inhibitory neurons compared with excitatory neurons [39, 132] . However, inhibition can suppress excitatory activity below the baseline resulting in net negative DCMRO 2 , and experimental studies combining 2PLM with controlled manipulation of neuronal circuits will be required to evaluate the net DCMRO 2 across different respective levels of excitation and inhibition.
Human translation
In the previous section, we were discussing the problem of estimation of neuronal activity given macroscopic CBF, CMRO 2 and current dipole. For human translation, a separate and equally important problem is how to reliably estimate these macroscopic physiological parameters from non-invasive measurements. This problem is particularly severe for CMRO 2 requiring two different types of measurements-BOLD and ASL-plus a calibration step [17] [18] [19] (CBF can be extracted from ASL using well-tested methods [158] [159] [160] ; estimation of current dipole moment with MEG/EEG is also straightforward as long as the location of neuronal activity and cortical orientation is known [161] ). In current practice, CMRO 2 in human imaging studies is estimated using simplified, macroscopic models that fit the fMRI response by assuming a specific functional form for the relationship between the spatially averaged, or 'lumped', physiological parameters of interest and the macroscopic imaging signals [17, 162, 163] . One specific example is the Davis model that was originally derived from simplified physiological assumptions to estimate relative changes in CMRO 2 from calibrated BOLD measurements [17] (ASL provides a direct measurement of CBF; no modelling is required). However, such CMRO 2 estimates have never been validated against direct measurements of the physiological parameters in question.
Bottom-up simulators of the fMRI signals can provide the ground truth for validation of these simplified macroscopic models. The first study of this kind is that by Gagnon et al. [164] . Gagnon et al. used the VAN model, based on the fundamental physiological processes with a microscopic level of detail, to simulate BOLD and ASL signals bottom-up. The simulated BOLD and ASL signals provided the input into the Davis model for estimation of the CMRO 2 change. This estimate was then compared to the true CMRO 2 known from VAN. The results revealed that to get a valid CMRO 2 estimate, the free parameters of the Davis model (known as a and b) had to assume values inconsistent with the physiological effects they were originally introduced to represent. The obvious limitation here is that if any of these parameters require adjustment to fit the data under certain conditions (e.g. in disease or ageing) this adjustment cannot be interpreted in terms of the underlying physiology.
In the future, calibration against large-scale realistic simulations where both the micro-and macroscopic reality is known will be essential for arriving at macroscopic models that would provide accurate estimation of CMRO 2 with model parameters derived from valid physiological assumptions. Ultimately, we would need to come up with a Davis-like formalism with a few model parameters. However, more detailed analytical models (still simplified compared to VAN), such as the one recently developed by Griffeth & Buxton [165] , may be very useful as an intermediate step. In contrast to VAN, which gives only the empirical relationship, the Griffeth et al. [15] model analytically captures the results of the bottom-up, microscopic simulation and thus can be used to study a mathematical relationship between interpretable parameters. Eventually, models like that in Griffeth et al. [15] would need to be reduced to obtain a simpler top-down, Davis-like formalism applicable to human fMRI experiments.
Neuronal circuits in mice and humans
The principle of leveraging mechanistic neurovascular/ neurometabolic insights obtained in animals for physiological underpinning of human data relies on the assumption of similar/comparable neuronal network activity. What are the reasons to believe that this assumption is valid? Figure 8 shows an example Somatosensory Evoked Field (SEF) response to the median nerve stimulation in a normal human subject obtained with MEG ( figure 8a,b ) and the equivalent current dipole moment calculated from laminar LFP in response to forepaw stimulation in an anaesthetized rat ( figure 8c,d ). These dipole time courses are remarkably similar, indicating similar patterns of evoked neuronal circuit activity in the rodent and human SI. For example, in both cases the response to the contralateral stimulus is composed of the initial negative peak followed by a positive one. These peaks occur earlier in the rat (12/21 ms) compared to the human (20/ 35 ms) due to differences in the distance that neuronal impulses have to travel. The human SEF has a secondary positive peak that is less pronounced in the rat; this difference may be attributed to anaesthesia. Thus, at least in the SI, the basic circuit function is preserved from rodents to humans, although physical scaling laws would need to be applied to account for systematic differences (e.g. longer electrical conduction times in humans). That being said, specific differences between these two species have been documented, including neuronal and astrocytic morphology and function and long-range connectivity [166] [167] [168] , and should be considered while translating model parameters from mouse to human.
Translation from the micro-to macroscopic scale inevitably results in loss of information, and activation of some cell-typespecific neuronal populations would have similar signatures in the macroscopic observables. The multimodal imaging approach aims to overcome this fundamental degeneracy of macroscopic measurements, as much as possible, by a combination of measurements. For example, inhibitory inputs to the top (apical) dendrites of PCs produce the same polarity of the macroscopic current dipole (and of the surface potential) as excitatory inputs to the basal dendrites (figure 8e). Likewise, excitatory inputs to the top cannot be distinguished from inhibitory inputs to the bottom. However, only inhibitory activity produces vasoconstriction [63] ( figure 3 ). Therefore, a combination of the current dipole and CBF response can disambiguate between these possibilities. 
Conclusion
How can we explicitly estimate the cellular level of neuronal functional organization in humans where we do not have access to microscopic measurements of any kind? All that we have is non-invasive measurements that can be thought of as 'observations from a distance' of signals with indirect relationship to the parameters of interest-neuronal activity at the level of specific cell types. In this essay, we argued that the activation of different neuronal cell types has different signatures in the evoked CBF, CMRO 2 and the macroscopic current dipole responses, and that by measuring these responses non-invasively in the human brain we will be able to probe more deeply the underlying neuronal circuit activity. We sketched a path for estimation of cell-type-specific neuronal activity from non-invasive measurements that begins with identification of the vasoactive role, energetic costs and extracellular electrical potentials/currents associated with activity of specific neuronal cell types. These types of experiments require experimental tools for microscopic measurement and manipulation that are only available in model organisms. These data are needed to simulate non-invasive measurements bottomup and build a comprehensive multiscale forward model connecting the dots between neuronal activity at the level of specific cell types to fMRI and MEG/EEG observables. For inference of neuronal activity in humans, this forward model would need to be combined with a set of non-invasive experimental measurements in a Bayesian approach [33] . Following this path may lead to a paradigm shift in human fMRI studies: from a simple mapping of fMRI signal change to the explicit estimation of the respective activity levels of specific neuronal cell types, providing a bridge between a large body of cellular and circuit-level neuroscience knowledge achieved in animals and the human 'measurables' and opening the door for human hypothesis-driven experiments that are currently unfeasible.
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